We evaluated the cost‐effectiveness of high‐flow nasal cannula (HFNC) to provide
additional oxygen for infants with bronchiolitis, compared to standard low‐flow therapy. The …

OBJECTIVES: High-flow nasal cannula (HFNC) use has increased in patients with
bronchiolitis, with the majority of use restricted to the ICU. Broadening HFNC to the wards …

Aim We aimed to describe the characteristics and outcomes of infants with bronchiolitis who
received high‐flow nasal cannula oxygen (HFNC) following a two‐tiered approach. Methods …

Background High-flow nasal cannula (HFNC) oxygen is a non-invasive ventilation system
that was introduced as an alternative to CPAP (continuous positive airway pressure), with a …

The proliferationof observational literature on the topic of high-flow nasal cannula (HFNC) as
a therapy for acute viral bronchiolitis is nothing short of remarkable. A brief PubMed search …

Bronchiolitis continues to be the most common cause of hospitalization in the first year of life.
We continue to search for the remedy that will improve symptoms, shorten hospitalization …

Aim An observational study was carried out on infants with moderate to severe bronchiolitis
to compare the clinical outcomes following treatment with a high‐flow nasal cannula (HFNC) …

Aim Bronchiolitis is a common condition in the paediatric population. Severe cases often
receive respiratory support with high‐flow nasal cannula (HFNC). Significant variation in the …

Background Bronchiolitis imposes the largest health care burden on non-elective paediatric
hospital admissions worldwide, with up to 15% of cases requiring admission to intensive …

Aim To obtain data on the safety and clinical impact of managing infants with bronchiolitis on
the ward with high‐flow nasal cannula (HFNC) treatment. Methods A prospective pilot study …